Fengtao Luo Selected Research

CATSHL syndrome

1/2020

Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fengtao Luo Research Topics

Disease

4	Osteoarthritis 01/2021 - 12/2012
2	Arthritis (Polyarthritis) 01/2020 - 12/2012
2	Scoliosis 01/2020 - 04/2019
2	Craniosynostoses (Craniosynostosis) 12/2018 - 11/2017
2	Acrocephalosyndactylia (Apert Syndrome) 12/2018 - 11/2017
2	Hypertrophy 12/2017 - 04/2016
2	Thanatophoric Dysplasia (Dwarfism, Thanatophoric) 12/2012 - 09/2012
2	Achondroplasia 12/2012 - 09/2012
1	Intervertebral Disc Degeneration 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021
1	Experimental Arthritis 10/2021
1	Hearing Loss (Hearing Impairment) 01/2020
1	CATSHL syndrome 01/2020
1	Cartilage-hair hypoplasia 11/2019
1	Inflammation (Inflammations) 12/2017
1	Bone Resorption 11/2017
1	Bone Fractures (Bone Fracture) 01/2017
1	Carcinogenesis 06/2015
1	Chondroma (Enchondroma) 06/2015
1	Neoplasms (Cancer) 06/2015
1	Wounds and Injuries (Trauma) 12/2012
1	Dwarfism 09/2012

Drug/Important Bio-Agent (IBA)

3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020 - 09/2012
3	CateninsIBA 01/2020 - 11/2017
2	Therapeutic UsesIBA 10/2021 - 12/2012
2	Biological ProductsIBA 01/2020 - 01/2017
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2018 - 11/2017
2	Proteoglycans (Proteoglycan)IBA 12/2017 - 12/2012
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2015 - 12/2012
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	anemoninIBA 12/2017
1	Anabolic AgentsIBA 11/2017
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 04/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2015
1	Peptides (Polypeptides)IBA 12/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2012
1	AntigensIBA 12/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2012
1	Intra-Articular Injections 04/2016